You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 88 No. 3, SEPTEMBER 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

EFFECT OF CORTICOTROPHIN AND CORTISONE ON THE BLOOD IN VARIOUS DISORDERS IN MAN

M. M. WINTROBE, M.D.; G. E. CARTWRIGHT, M.D.; J. G. PALMER, M.D.; W. J. KUHNS, M.D.; L. T. SAMUELS, Ph.D.

AMA Arch Intern Med. 1951;88(3):310-336.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SINCE the discovery that corticotrophin (ACTH) and cortisone exert beneficial effects on a wide variety of disease processes which had not been considered previously to be primarily hormonal in nature, a number of patients with disorders of the blood have been treated with these agents. This report describes our own studies in 40 cases. A preliminary report of the observations on 24 of these cases has been published.1 It is now well known that lymphopenia and neutrophilia develop in experimental animals2 and in man3 after administration of corticotrophin. The reduction in circulating eosinophils which follows administration of corticotrophin has been used as a test for adrenal-cortical insufficiency.4 Alterations have also been produced by corticotrophin and cortisone in various disease processes involving the leucocytes. Thus, improvement after corticotrophin therapy has been seen in a number of cases of acute leukemia, with "complete" temporary remissions in some. Improvement . . . [Full Text PDF of this Article]


Author Affiliations

SALT LAKE CITY

From the Departments of Medicine and Biochemistry, College of Medicine, University of Utah.


Footnotes

Dr. Palmer is a Fellow of the American Cancer Society.

Dr. Kuhns is a Fellow of the United States Public Health Service.

These studies were aided by grants from the United States Public Health Service and the Damon Runyon Memorial Fund for Cancer Research.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.